1 reports of this reaction
2.4% of all POTASSIUM DICHROMATE reports
#8 most reported adverse reaction
ARTHRALGIA is the #8 most commonly reported adverse reaction for POTASSIUM DICHROMATE, manufactured by BM Private Limited. There are 1 FDA adverse event reports linking POTASSIUM DICHROMATE to ARTHRALGIA. This represents approximately 2.4% of all 41 adverse event reports for this drug.
Patients taking POTASSIUM DICHROMATE who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is a less commonly reported adverse event for POTASSIUM DICHROMATE, but still significant enough to appear in the safety profile.
In addition to arthralgia, the following adverse reactions have been reported for POTASSIUM DICHROMATE:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 1 FDA reports for POTASSIUM DICHROMATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 2.4% of all adverse event reports for POTASSIUM DICHROMATE, making it a notable side effect.
If you experience arthralgia while taking POTASSIUM DICHROMATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.